Climb Bio Share Price Today
(NASDAQ: CLYM)

Name: Climb Bio Share Price Today (NASDAQ: CLYM) - Climb Bio Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Climb Bio share price is $1.41 & ₹122.63 as on 6 Mar 2025, 2.30 'hrs' IST

$1.41

▲

0.03

(2.17%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Climb Bio share price in Dollar and Rupees. Guide to invest in Climb Bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Climb Bio, along with analyst recommendations, forecasts, and comprehensive financials.

Climb Bio share price movements

Today's Low: $1.33
Today's High: $1.43
$1.41
5.67%
Downside
Day's Volatility :6.99%
Upside
1.4%
52 Weeks Low: $1.30
52 Weeks High: $5.86
$1.41
7.8%
Downside
52 Weeks Volatility :77.82%
Upside
75.94%

Climb Bio (CLYM) Returns

Period	Climb Bio Inc	Index (Russel 2000)
3 Months	-52.58%	0.0%
6 Months	-81.77%	0.0%
1 Year	-50.54%	0.0%
3 Years	-85.4%	-11.6%

Climb Bio (CLYM) Key Statistics

in dollars & INR

Previous Close	$1.38
Open	$1.43
Today's High	$1.43
Today's Low	$1.33
Today's Volume	$76.5K
52 Week High	$5.86
52 Week Low	$1.3
Revenue TTM	$0.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Climb Bio Stock (CLYM) from India?

It is very easy for Indian residents to invest directly in Climb Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Climb Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Climb Bio or CLYM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Climb Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Climb Bio shares which would translate to 0.617 fractional shares of Climb Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Climb Bio, in just a few clicks!

Returns in Climb Bio (CLYM) for Indian investors in Rupees

The Climb Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Climb Bio investment value today

Current value as on today

₹55,500

Returns

₹44,500

(-44.5%)

Returns from Climb Bio Stock

₹49,462 (-49.46%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Climb Bio (CLYM)

-57%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Climb Bio Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Climb Bio

Insights on Climb Bio Stock (Ticker Symbol: CLYM)

Price Movement
In the last 3 months, CLYM stock has moved down by -52.6%
CLYM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 113.4%
CLYM vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 132.6%

Climb Bio Technicals Summary

Sell

Neutral

Buy

Climb Bio is currently in a neutral trading position according to technical analysis indicators.

Climb Bio (CLYM) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Climb Bio Inc	-26.2%	-81.77%	-50.54%	-85.4%	-91.32%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Climb Bio Inc	NA	NA	NA	0.0	0.0	0.0	NA	NA
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Climb Bio Inc	NA	NA	-91.32%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Climb Bio

Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Organization	Climb Bio
Employees	9
CEO	Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Industry	Miscellaneous

Management People of Climb Bio

Name	Title
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc	CEO, President & Director
Dr. Brett Kaplan M.B.A., M.D.	COO & Principal Financial Officer
Ms. Emily Pimblett CPA	Senior VP of Finance & Chief Accounting Officer
Dr. Nishi Rampal M.D.	Senior Vice President of Clinical Development
Ms. Janaki Subramanyam M.Sc.	VP & Head of Regulatory Affairs
Ms. Kate Hecht M.B.A.	Senior Vice President of Program Management
Dr. William Bonificio Ph.D.	Interim Chief Business Officer
Dr. Perrin Wilson B.S., Ph.D.	Chief Business Officer

Important FAQs about investing in CLYM Stock from India :

What is Climb Bio share price today?

Climb Bio share price today stands at $1.41, Open: $1.43 ; Previous Close: $1.38 ; High: $1.43 ; Low: $1.33 ; 52 Week High: $5.86 ; 52 Week Low: $1.30.

The stock opens at $1.43, after a previous close of $1.38. The stock reached a daily high of $1.43 and a low of $1.33, with a 52-week high of $5.86 and a 52-week low of $1.30.

Can Indians buy Climb Bio shares?

Yes, Indians can invest in the Climb Bio (CLYM) from India.

With INDmoney, you can buy Climb Bio at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Climb Bio at zero transaction cost.

How can I buy Climb Bio shares from India?

It is very easy to buy Climb Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Climb Bio (CLYM) be purchased?

Yes, you can buy fractional shares of Climb Bio with INDmoney app.

What are the documents required to start investing in Climb Bio stocks?

To start investing in Climb Bio, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.